Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation.

Gillen DL, Stehman-Breen CO, Smith JM, McDonald RA, Warady BA, Brandt JR, Wong CS.

Am J Transplant. 2008 Dec;8(12):2600-6. doi: 10.1111/j.1600-6143.2008.02410.x. Epub 2008 Sep 18.

2.

Cardiovascular risk factors and incident acute renal failure in older adults: the cardiovascular health study.

Mittalhenkle A, Stehman-Breen CO, Shlipak MG, Fried LF, Katz R, Young BA, Seliger S, Gillen D, Newman AB, Psaty BM, Siscovick D.

Clin J Am Soc Nephrol. 2008 Mar;3(2):450-6. doi: 10.2215/CJN.02610607. Epub 2008 Feb 6.

3.

Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study.

O'Hare AM, Newman AB, Katz R, Fried LF, Stehman-Breen CO, Seliger SL, Siscovick DS, Shlipak MG.

Arch Intern Med. 2005 Dec 12-26;165(22):2666-70.

PMID:
16344426
4.

Cystatin C and subclinical brain infarction.

Seliger SL, Longstreth WT Jr, Katz R, Manolio T, Fried LF, Shlipak M, Stehman-Breen CO, Newman A, Sarnak M, Gillen DL, Bleyer A, Siscovick DS.

J Am Soc Nephrol. 2005 Dec;16(12):3721-7. Epub 2005 Oct 19.

5.

Cystatin C concentration as a risk factor for heart failure in older adults.

Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG; Cardiovascular Health Study.

Ann Intern Med. 2005 Apr 5;142(7):497-505.

PMID:
15809461
6.

Increased risk of mortality associated with hip fracture in the dialysis population.

Mittalhenkle A, Gillen DL, Stehman-Breen CO.

Am J Kidney Dis. 2004 Oct;44(4):672-9.

PMID:
15384018
7.

Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study.

Seliger SL, Siscovick DS, Stehman-Breen CO, Gillen DL, Fitzpatrick A, Bleyer A, Kuller LH.

J Am Soc Nephrol. 2004 Jul;15(7):1904-11.

8.

Parathyroidectomy rates among United States dialysis patients: 1990-1999.

Kestenbaum B, Seliger SL, Gillen DL, Wasse H, Young B, Sherrard DJ, Weiss NS, Stehman-Breen CO.

Kidney Int. 2004 Jan;65(1):282-8.

9.

Cardiovascular and thromboembolic events following hypertensive pregnancy.

Kestenbaum B, Seliger SL, Easterling TR, Gillen DL, Critchlow CW, Stehman-Breen CO, Schwartz SM.

Am J Kidney Dis. 2003 Nov;42(5):982-9.

PMID:
14582042
10.

Hepatitis C and renal disease: an update.

Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH.

Am J Kidney Dis. 2003 Oct;42(4):631-57. Review.

PMID:
14520615
11.

Risk factors for incident stroke among patients with end-stage renal disease.

Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO.

J Am Soc Nephrol. 2003 Oct;14(10):2623-31.

12.

Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients.

Wasse H, Gillen DL, Ball AM, Kestenbaum BR, Seliger SL, Sherrard D, Stehman-Breen CO.

Kidney Int. 2003 Oct;64(4):1455-61.

13.

Racial differences in early-onset renal disease among young adults: the coronary artery risk development in young adults (CARDIA) study.

Stehman-Breen CO, Gillen D, Steffes M, Jacobs DR Jr, Lewis CE, Kiefe CI, Siscovick D.

J Am Soc Nephrol. 2003 Sep;14(9):2352-7.

14.

Elevated risk of stroke among patients with end-stage renal disease.

Seliger SL, Gillen DL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO.

Kidney Int. 2003 Aug;64(2):603-9.

15.

Are HMG-CoA reductase inhibitors underutilized in dialysis patients?

Seliger SL, Stehman-Breen CO.

Semin Dial. 2003 May-Jun;16(3):179-85. Review.

PMID:
12753674
16.

Increased risk of preeclampsia among nulliparous pregnant women with idiopathic hematuria.

Stehman-Breen CO, Levine RJ, Qian C, Morris CD, Catalano PM, Curet LB, Sibai BM.

Am J Obstet Gynecol. 2002 Sep;187(3):703-8.

PMID:
12237651
17.

Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease.

Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO.

Kidney Int. 2002 Feb;61(2):630-7.

18.

HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients.

Seliger SL, Weiss NS, Gillen DL, Kestenbaum B, Ball A, Sherrard DJ, Stehman-Breen CO.

Kidney Int. 2002 Jan;61(1):297-304.

20.

Use of the vascular diagnostic laboratory in improving the success of angioaccess procedures.

Gibson KD, Stehman-Breen CO, Kohler TR.

Semin Vasc Surg. 2001 Sep;14(3):222-6. Review.

PMID:
11561284
21.

Risk factors and mortality associated with calciphylaxis in end-stage renal disease.

Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis CL, Stehman-Breen CO.

Kidney Int. 2001 Jul;60(1):324-32.

22.

Assessment of a policy to reduce placement of prosthetic hemodialysis access.

Gibson KD, Caps MT, Kohler TR, Hatsukami TS, Gillen DL, Aldassy M, Sherrard DJ, Stehman-Breen CO.

Kidney Int. 2001 Jun;59(6):2335-45.

23.

Risk factors for hip fracture among patients with end-stage renal disease.

Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS, Ball A, Weiss NS.

Kidney Int. 2000 Nov;58(5):2200-5.

24.

Determinants of type and timing of initial permanent hemodialysis vascular access.

Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M.

Kidney Int. 2000 Feb;57(2):639-45.

25.

Prescription of hormone replacement therapy in postmenopausal women with renal failure.

Stehman-Breen CO, Gillen D, Gipson D.

Kidney Int. 1999 Dec;56(6):2243-7.

26.

The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.

Al-Douahji M, Brugarolas J, Brown PA, Stehman-Breen CO, Alpers CE, Shankland SJ.

Kidney Int. 1999 Nov;56(5):1691-9.

27.

Racial differences in bone mineral density and bone loss among end-stage renal disease patients.

Stehman-Breen CO, Sherrard D, Walker A, Sadler R, Alem A, Lindberg J.

Am J Kidney Dis. 1999 May;33(5):941-6.

PMID:
10213653
28.

Risk of death among chronic dialysis patients infected with hepatitis C virus.

Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ.

Am J Kidney Dis. 1998 Oct;32(4):629-34.

PMID:
9774125
29.

Increased risk of adverse maternal and infant outcomes among women with renal disease.

Fink JC, Schwartz SM, Benedetti TJ, Stehman-Breen CO.

Paediatr Perinat Epidemiol. 1998 Jul;12(3):277-87.

PMID:
9690263
30.

Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients.

Stehman-Breen CO, Psaty BM, Emerson S, Gretch D, Bronner M, Marsh C, Davis CL.

Transplantation. 1997 Jul 27;64(2):281-6.

PMID:
9256188

Supplemental Content

Loading ...
Support Center